122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Children's Cancer Study Group.
Finkelstein JZ, Lenarsky C, Ladisch S et al. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Children's Cancer Study Group. Med. Pediatr. Oncol. 1992 20 : 307 11.
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
Marthay KK, Villablanca JQ, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N. Engl. J. Med. 1999 341 : 1165 73.
Intensified chemotherapy increases the survival rate in patients with stage 4 neuroblastoma with MYCN amplification
Kaneko M, Tsuchida Y, Mugishima H et al. Intensified chemotherapy increases the survival rate in patients with stage 4 neuroblastoma with MYCN amplification. J. Pediatr Hematol Oncol. 2002 24 : 613 21.
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation
Villablanca JG, Khan AA, Avramis VI et al. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J. Clin. Oncol. 1995 13 : 894 901.